Australia markets closed

Genetic Technologies Limited (GTG.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.16500.0000 (0.00%)
At close: 11:42AM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-58.75%
S&P500 52-week change 321.61%
52-week high 30.4000
52-week low 30.0960
50-day moving average 30.1685
200-day moving average 30.2207

Share statistics

Avg vol (3-month) 38.68k
Avg vol (10-day) 33.64k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8101.76M
% held by insiders 111.83%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.01:1
Last split date 314 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -124.08%
Operating margin (ttm)-105.96%

Management effectiveness

Return on assets (ttm)-52.71%
Return on equity (ttm)-160.47%

Income statement

Revenue (ttm)10.24M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)-2.10%
Gross profit (ttm)N/A
EBITDA -9.86M
Net income avi to common (ttm)-12.71M
Diluted EPS (ttm)-0.0010
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.73M
Total cash per share (mrq)0.03
Total debt (mrq)382.32k
Total debt/equity (mrq)7.95%
Current ratio (mrq)1.67
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)-7.6M
Levered free cash flow (ttm)-4.6M